FDA Pathway to Approval: Clinical Requirements for Renal Denervation - K. J. Cavanaugh, PhD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

FDA Pathway to Approval: Clinical Requirements for Renal Denervation presented by K. J. Cavanaugh, PhD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians

Session Name: Future Clinical Trial Designs and Regulatory Requirements to Assess Efficacy of Devices for the Treatment of Renal Denervation

Track: Technology & Innovation

Learning Objectives

  • Updates in Renal Denervation and Hypertension Therapies
Loading Simple Education